Families of older people dying of progressive chronic disease often feel insufficiently informed about the course of the illness, so when death occurs it can be felt as a surprise. However, this misperception of an ‘unexpected death’ could be minimised if only we provided our patients and their loved ones with information that includes an […]
Resurgence of Ebola in Butembo, North Kivu in the Democratic Republic of the Congo: Brazzaville – The Ministry of Health of the DRC today announced that a new case of Ebola has been detected in Butembo, a city in North Kivu Province, where a previous outbreak was declared over in June 2020. The Butembo branch of the […]
Read More… from Resurgence of Ebola in Butembo, North Kivu DRC
Oxytocin/vasopressin receptors are typical examples of so-called G protein-coupled receptors – the most successful drug target class. The oxytocin and vasopressin receptors are targeted, for example, during childbirth to encourage contractions but are also being investigated for therapeutic applications in cardiovascular disease, cancer, and developmental disorders such as autism. Inspired by locusts MedUni Vienna researchers […]
Read More… from New drug development using Nature’s strategies
Our consumer products, such as food, cosmetics and clothes, might be filled with nanomaterials – unbeknownst to us. The use of nanomaterials remains unregulated and they do not show up in lists of ingredients. This is a cause of concern since nanomaterials can be more dangerous than COVID-19 in the long term if no safety […]
Read More… from The invisible killer lurking in our consumer products
Genetic screening before prescribing could benefit millions: Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands). Researchers looked through 2019 NHS dispensing data across the UK to see how […]
COVID-19 cases and deaths are surging in Africa as new, more contagious variants of the virus spread to additional countries. Over 175 000 new COVID-19 cases and more than 6200 deaths were reported in Africa in the last week while infections rose by 50% on the continent between 29 December 2020 and 25 January 2021 […]
Read More… from New COVID-19 variants fuelling Africa’s second wave
Researchers from the University of Nottingham have discovered a novel antiviral property of a drug that could have major implications in how future epidemics / pandemics – including Covid-19 – are managed. The study, published in Viruses*, shows that thapsigargin is a promising broad‑spectrum antiviral, highly effective against Covid-19 virus (SARS-CoV-2), a common cold coronavirus, respiratory syncytial […]
Read More… from Scientists uncover potential antiviral treatment for Covid-19
What is multiple sclerosis? Multiple sclerosis is a chronic and progressive neurological disease that results in neuronal cell death, which can lead to a variety of symptoms. Find more videos at https://www.osmosis.org/product/library. Transcript Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord. Myelin is the […]
Read More… from Multiple sclerosis – causes, symptoms, diagnosis, treatment, pathology
A new World Health Organization (WHO) road map for neglected tropical diseases (NTDs) proposes ambitious targets and innovative approaches to tackle 20 diseases which affect more than a billion mainly poor people and which thrive in areas where access to quality health services, clean water and sanitation is scarce. Targets include the eradication of dracunculiasis (guinea worm) […]
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research (NIHR). The team are initially looking for up to 400 care homes to take part in the ground-breaking trial – […]
Read More… from New trial to test drugs for preventing Covid-19 in care homes